Published in Cancer Weekly, March 29th, 2011
"Although DNA microarray-based gene expression profiling (GEP) remains unlikely in the near term to completely replace morphological...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.